4Yin H, Leong AS. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up[J]. Am J Clin Pathol,2004, 121 (5) :679 - 687.
5Holmang S, Hedelin H, Anderstrom C, et al. Recurrence and progression in low grade papillary urothelial tumors[ J]. J Urol, 1999, 162(3) :702 - 70?.
6Eble JN, sauter G, Epstein JI, et al. World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs[ M]. Lyon: IARC Press,2004. 90.
7Suwa Y, Takano Y, Iki M, et al. Prognostic significance of Ki-67 expression in transitional cell bladder carcinoma after radical cystectomy[J]. Pathol Res Pract, 1997,193(8) :551 - 556.
8Pich A, Chiusa L, Formiconi A, et al. Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade(grade 1)papillary carcinomas of the bladder[J]. Am J Surg Pathol,2001,25(12) : 1528 - 1533.
9Sou Z, Su W, Holm R, et al. Lack of expression of c-erbB-2 oncoprotein in human esophageal squamous cell carcinoma [J].Anticancer Res, 1995,15 (6B) : 2797 - 2798.
10Marchetti P,Castedo M,Susin SA,et al.Mitochondrial permeabilitytransition is a central coordinating event of apoptosis[J].JEM,1996,184 (3):1105-1106.
